Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma
- Sponsor
- University of Cologne
- Study ID
- NCT00147953
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Rituximab — DRUG
- Total nodal irradiation — PROCEDURE
Study Details
This study aims to assess the short term efficacy of a combination of rituximab and low-dose radiotherapy in patients with non-Hodgkin's lymphoma.
Key Dates
- Start date
- Jun 30, 2004
- Status verified
- Jan 2010
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Primary Outcome Measure
Overall response rate (complete and partial response rate)
Related Studies
- Establishing a Tumor Bank in Families With Multiple Lymphoproliferative MalignanciesRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALEPHASE1 · Recruiting · Baylor College of Medicine · Houston, Texas
- The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative RegimenRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- ID Of Prognostic Factors In Mycosis Fungoides/Sezary SyndromeRecruiting · Stanford University · Duarte, California